The Claim
Genetically predicted loss of PCSK9 function, which lowers LDL cholesterol by approximately 2.65 mg/dL per standard deviation in White individuals, is associated with a 17% reduced risk of coronary artery disease in a multi-ethnic cohort of 312,097 individuals, with an odds ratio of 0.83 (95% CI: 0.80–0.87, p = 6.0 × 10⁻²¹), indicating that lifelong lower LDL-C due to PCSK9 inhibition strongly correlates with lower incidence of coronary artery disease across diverse populations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People who naturally have a broken PCSK9 gene — which keeps their bad cholesterol low their whole life — are much less likely to get heart disease, and this seems to be true for people of many different backgrounds.
See the scientific wording
Genetically predicted loss of PCSK9 function, which lowers LDL cholesterol by approximately 2.65 mg/dL per standard deviation in White individuals, is associated with a 17% reduced risk of coronary artery disease in a multi-ethnic cohort of 312,097 individuals, with an odds ratio of 0.83 (95% CI: 0.80–0.87, p = 6.0 × 10⁻²¹), suggesting lifelong lower LDL-C due to PCSK9 inhibition strongly correlates with lower CAD incidence across diverse populations.
What the research says
1 studyThe study looked at people with natural changes in the PCSK9 gene that lower cholesterol, and found they have a lower risk of heart disease — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.